Cargando…
Epratuzumab inhibits the production of the proinflammatory cytokines IL-6 and TNF-α, but not the regulatory cytokine IL-10, by B cells from healthy donors and SLE patients
INTRODUCTION: Cytokines produced by B cells are believed to play important roles in autoimmune diseases. CD22 targeting by epratuzumab has been demonstrated to inhibit phosphorylation of B cell receptor (BCR) downstream signaling in B cells. It has been shown that other sialoadhesin molecules relate...
Autores principales: | Fleischer, Vanessa, Sieber, Julia, Fleischer, Sarah J., Shock, Anthony, Heine, Guido, Daridon, Capucine, Dörner, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504352/ https://www.ncbi.nlm.nih.gov/pubmed/26183319 http://dx.doi.org/10.1186/s13075-015-0686-2 |
Ejemplares similares
-
Active systemic lupus erythematosus is associated with a reduced cytokine production by B cells in response to TLR9 stimulation
por: Sieber, Julia, et al.
Publicado: (2014) -
Effect of Proinflammatory Cytokines (IL-6, TNF-α, and IL-1β) on Clinical Manifestations in Indian SLE Patients
por: Umare, Vinod, et al.
Publicado: (2014) -
Epratuzumab targeting of CD22 affects adhesion molecule expression and migration of B-cells in systemic lupus erythematosus
por: Daridon, Capucine, et al.
Publicado: (2010) -
Proinflammatory cytokines IL-6 and TNF-α and the development of inflammation in obese subjects
por: Popko, K, et al.
Publicado: (2010) -
Exosomes secreted by Blastocystis subtypes affect the expression of proinflammatory and anti-inflammatory cytokines (TNFα, IL-6, IL-10, IL-4)
por: Norouzi, Mojtaba, et al.
Publicado: (2022)